Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

VRCAVRCA
4 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in VERRICA PHARMACEUTICALS INC

Yes. BNP Paribas Financial Markets holds 110 shares of VRCA (Verrica Pharmaceuticals), worth $673, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. BNP Paribas Financial Markets has held VRCA in every 13F on record since Q3 2025, 4 quarterly filings.

Current Value

$673

Current Shares

110

Total Value Change

+$139

Total Shares Change

-14

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
110
0.0%
$6730.0%$6.12
0
2026-Q1
Unchanged
110
0.0%
$5820.0%$5.12
0
2025-Q4
Decreased
110
-11.3%
$9140.0%$8.30
0
2025-Q3
New
124
-
$5340.0%$4.30
17

Other major holders of VRCA: VANGUARD CAPITAL MANAGEMENT LLC, Mariner, LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used